Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
The United States announces a 100% tariff increase on imported patented drugs and pharmaceutical ingredients.
Golden Finance reports that on April 3, the White House in the United States said in a statement released on April 2 that U.S. President Trump signed a document that day. Under Section 232 of the Trade Expansion Act of 1962, the U.S. will impose a 100% tariff on imported patent drugs and pharmaceutical ingredients. The measure also provides a path for exemptions or tariff reductions, aiming to pressure pharmaceutical companies into reaching agreements with the White House on drug prices and the return of industry, among other things. (Xinhua News Agency)